Biotechnology | COVID-19 | FDA | Therapeutics
XBiotech announced COVID-19 candidate therapy
On Aug. 24, 2020, XBiotech announced that the U.S. Food and Drug Administration (FDA) issued an emergency use…
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…
Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaﾮ SARS…
Experimental COVID-19 vaccine prevented severe disease in mice
On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…
Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray
On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…
Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy
On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…
FDA approved teatment for rare disease affecting optic nerves, spinal cord
On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…
Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
Sanofi acquired Principia Biopharma for $3.68 billion
On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…
XBiotech announced COVID-19 candidate therapy
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
NIH-supported research demonstrates how genetic variations cause eczema
On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…
Vaccine refusal and measles outbreaks increased in the U.S.
On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…
Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
ADHD risk may be linked to inflammation during pregnancy
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
Biotechnology | COVID-19 | Influenza | NIH
Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
Biotechnology | HIV | Infectious Disease | Medicine | Therapeutics | Vaccine | WHO
China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…
Biotechnology | Disease | FDA | Therapeutics
FDA approved oral treatment for spinal muscular atrophy
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate
On Aug. 7, 2020, Altimmune announced that it had completed enrollment in its Phase 1b clinical trial of…
Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
RedHill Biopharma’s phase 2/3 COVID-19 study approved in Mexico
On Aug. 6, 2020, RedHill Biopharma announced approval from the Mexican Federal Committee for the Protection against Sanitary…